The inhibition of mGluR1 with the silencing of RNA was shown to reduce the viability, invasiveness, and migratory activities of human glioma cells (U87) in vitro, and reduced U87 tumor progression in vivo [88]. The gene discussed is GRM1; the disease is glioma.